ANN ARBOR, Mich. — January 20, 2026 — Leads & Copy — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is embarking on an ambitious genetic engineering initiative to enhance the strength and elasticity of recombinant spider silk. The company’s research and development team has completed the construction phase of advanced spider silk gene constructs and has started the execution phase of silkworm gene engineering and recombinant spider silk production.
Kim Thompson, Founder and CEO of Kraig Labs, said the project is a defining moment for the company’s technology platform. Thompson noted that the team has developed sophisticated spider silk gene constructs. He believes the initiative represents the most ambitious application of genetic engineering to material science and will surpass other efforts in biomimicry and molecular biology applications to material science.
The new genetic engineering program aims to drive innovation across Kraig Labs’ production pipeline, enhance fiber performance, and diversify products. The company anticipates that these efforts will reinforce its position as it advances toward commercial-scale spider silk manufacturing.
The company said that the program builds upon years of proprietary research and production experience and is designed to expand the performance, scalability, and commercial potential of the company’s spider silk technologies.
Kraig Biocraft Laboratories is the leading developer of genetically engineered spider silk-based fiber technologies. Recent advancements are available at www.kraiglabs.com/videos and on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. Recent news and company alerts are available at www.KraigLabs.com/news.
Ben Hansel, Hansel Capital, Inc. can be reached at (720) 288-8495 or ir@KraigLabs.com.
Source: Kraig Biocraft Laboratories, Inc.
